HLS Therapeutics Inc (HLS):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:HLS Therapeutics Inc (HLS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8150
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
HLS Therapeutics Inc (HLS Therapeutics) is a pharmaceutical company that offers central nervous system and cardiovascular therapeutic products. The company’s product includes clozaril, absorica, vascepa and trinomial. Its clozapine is a pharmaceutical product used in the treatment of schizophrenia. HLS Therapeutics offers novel therapies. The company offers services such as acquisition and commercialization of late-stage development, commercial-stage promoted and established branded pharmaceutical products. The company has its operations in Canada, Barbados and the US. HLS Therapeutics is headquartered in Toronto, Ontario, Canada.

HLS Therapeutics Inc (HLS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HLS Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
HLS Therapeutics Acquires Rights to Clozaril 10
Venture Financing 11
HLS Therapeutics Raises USD30 Million in Venture Financing 11
HLS Therapeutics Raises USD112.8 Million in Venture Financing 12
Partnerships 13
Amarin and HLS Therapeutics Enter into Agreement 13
Merger 14
HLS Therapeutics and Automodular Complete Merger 14
HLS Therapeutics Inc – Key Competitors 16
HLS Therapeutics Inc – Key Employees 17
HLS Therapeutics Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Aug 15, 2018: HLS Therapeutics Announces Q2 2018 Financial Results 19
May 16, 2018: HLS Therapeutics Announces Q1 2018 Financial Results 22
Mar 29, 2018: HLS Therapeutics Reports Fiscal 2017 Financial Results 24
Corporate Communications 26
Mar 16, 2018: HLS Therapeutics Opens Market 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HLS Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HLS Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
HLS Therapeutics Acquires Rights to Clozaril 10
HLS Therapeutics Raises USD30 Million in Venture Financing 11
HLS Therapeutics Raises USD112.8 Million in Venture Financing 12
Amarin and HLS Therapeutics Enter into Agreement 13
HLS Therapeutics and Automodular Complete Merger 14
HLS Therapeutics Inc, Key Competitors 16
HLS Therapeutics Inc, Key Employees 17
HLS Therapeutics Inc, Other Locations 18
HLS Therapeutics Inc, Subsidiaries 18

List of Figures
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[HLS Therapeutics Inc (HLS):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Supernus Pharmaceuticals Inc (SUPN):企業の財務・戦略的SWOT分析
    Supernus Pharmaceuticals Inc (SUPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Inpex Corp (1605):企業の財務・戦略的SWOT分析
    Inpex Corp (1605) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Banca Monte dei Paschi di Siena S.p.A.:戦略・SWOT・企業財務分析
    Banca Monte dei Paschi di Siena S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Banca Monte dei Paschi di Siena S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Terumo Corp (4543):企業の財務・戦略的SWOT分析
    Terumo Corp (4543) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Renishaw Plc (RSW):企業の財務・戦略的SWOT分析
    Summary Renishaw Plc (Renishaw) is a medical device company that designs, manufactures and markets measurement, motion control, spectroscopy and precision machining products. The company offers precision measurement and process control, position and motion control, 3D laser scanning and measurement, …
  • Sime Darby Berhad:戦略・SWOT・企業財務分析
    Sime Darby Berhad - Strategy, SWOT and Corporate Finance Report Summary Sime Darby Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Tenaga Nasional Berhad:企業の戦略・SWOT・財務情報
    Tenaga Nasional Berhad - Strategy, SWOT and Corporate Finance Report Summary Tenaga Nasional Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Cleco Corporate Holdings, Llc
    Cleco Corporate Holdings, Llc - Strategy, SWOT and Corporate Finance Report Summary Cleco Corporate Holdings, Llc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Global Tungsten & Powders Corp.:企業の戦略・SWOT・財務分析
    Global Tungsten & Powders Corp. - Strategy, SWOT and Corporate Finance Report Summary Global Tungsten & Powders Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Oxford Immunotec Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Oxford Immunotec Ltd (Oxford Immunotec) a subsidiary of Oxford Immunotec Global Plc is a medical device company that offers proprietary tests for immune-regulated conditions. The company offers in vitro diagnostic, T-SPOT CMV Test, C6 Lyme ELISA Test, T-Cell Xtend Reagent. It offers T-SPOT.T …
  • Texas Biomedical Research Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Texas Biomedical Research Institute (Texas Biomed) is a medical research institute that develops treatment for chronic and infectious diseases. The institute conducts biomedical research and discovers new technologies for preventing and eradicating infectious diseases. Its research program i …
  • Samsung Life Insurance Co Ltd:企業の戦略・SWOT・財務情報
    Samsung Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Samsung Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Itausa – Investimentos Itau S.A.:企業の戦略・SWOT・財務情報
    Itausa - Investimentos Itau S.A. - Strategy, SWOT and Corporate Finance Report Summary Itausa - Investimentos Itau S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Biotie Therapies Corp-製薬・医療分野:企業M&A・提携分析
    Summary Biotie Therapies Corp (Biotie) is a pharmaceutical company that discovers and develops new medicines for the treatment of various diseases. The company offers products for use in the treatment of neurodegenerative and psychiatric disorders such as parkinson's disease, alzheimer's disease, pr …
  • Nanologica AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Nanologica AB (Nanologica) develops nanoporous silica specializing in materials technology for clinical and chromatography applications. The company's proprietary technology NLAB Saga, a nanoporous silica media well-adapted for chromatography is used in analytical columns and for bulk manufa …
  • United Bank Of India:企業の戦略・SWOT・財務分析
    United Bank Of India - Strategy, SWOT and Corporate Finance Report Summary United Bank Of India - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Oman Oil Co SAOC:石油・ガス:M&Aディール及び事業提携情報
    Summary Oman Oil Company SAOC (Oman Oil Company) is an oil and gas service provider that offers investment facilities for the growth and development of energy sector. The association invests and develops the areas of production, exploration, and related services, energy infrastructure and shipping, …
  • NorgesGruppen ASA:企業の戦略的SWOT分析
    NorgesGruppen ASA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • DePuy Synthes Inc:企業の製品パイプライン分析2018
    Summary DePuy Synthes Inc (DePuy Synthes), a subsidiary of Johnson & Johnson, is a medical device company that provides products for orthopedic and neurological procedures. DePuy Synthes operates through eight divisions: joint reconstruction, sports medicine, neurological, spine, trauma, cranio-maxi …
  • Antibe Therapeutics Inc (ATE):医療機器:M&Aディール及び事業提携情報
    Summary Antibe Therapeutics Inc (Antibe) is a biotech company that designs and develops drug candidates for chronic pain and inflammation; and regenerative medicine. The company discovers and commercializes novel drugs, biologics and medical devices. It offers lead compound ATB-346, a naproxen deriv …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆